Patent Settlements in the Pharmaceutical Industry: What Can We Learn From Economic Analysis?

Patent settlements between originator and generic firms in the pharmaceutical industry have been challenged by antitrust and competition authorities in the U.S. and the EU. Particularly settlementswith large "reverse payments" to generic firms raise the concern of collusive behaviour for p...

Full description

Bibliographic Details

Published in:	MAGKS - Joint Discussion Paper Series in Economics (Band 01-2016)
Main Authors:	Frank, Severin, Kerber, Wolfgang
Format:	Article
Language:	English
Published:	Philipps-Universität Marburg 2015
Subjects:	pharmaceutical industry generic competition Wirtschaft Patent settlements probabilistic patents weak patents Economics
Online Access:	PDF Full Text
Tags:	Add Tag No Tags, Be the first to tag this record!